Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Follitropin Alfa 2026-08-27
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Pegfilgrastim, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Contrac 2026-08-27
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Teriparatide 2026-08-27
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Ustekinumab, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Contract 2026-08-27
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Infliximab For Subcutaneous Application 2026-08-27
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Etanercept, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Contract T 2026-08-27
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Denosumab 2026-08-27
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Epoetin Alfa + Zeta, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The C 2026-08-27
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Aflibercept, With A Contract Start Date Of 01.04.2026. All Interested Companies Can Join This Contract At Any Time Duri 2026-08-27
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Adalimumab, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Contract T 2026-08-27
Whats app